Clinical Study to Evaluate the Performance of Perimount Heart Valve in Chinese Patients
NCT ID: NCT02400489
Last Updated: 2022-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
265 participants
OBSERVATIONAL
2014-09-25
2020-06-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To track the patients'situations during one year after surgery and to collect the relevant clinical data.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Retrospective Study to Collect the Data From the Patients Who Had the Perimount Heart Valve Replacement Surgery in China During 2001 to 2007
NCT02381678
Early Feasibility Study of Surgical Implantation of a Polymer Prosthetic Mitral and Aortic Valve
NCT07097740
PERCEVAL S Valve Clinical Study for Chinese Registration
NCT03481387
Safety and Efficacy of Post-marketing Transcatheter Aortic Valves in "Real World" Chinese Patients
NCT06257043
Sapien 3 Transcatheter Aortic Valve Replacement in Young Aortic Valve Stenosis Patients From China
NCT06830499
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients sign the Inform Consent Form (ICF) and agree to join the study
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Edwards Lifesciences
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xufa Chen, M.D
Role: PRINCIPAL_INVESTIGATOR
Wuhan Asia Heart Hospital
Chengwei Zou, M.D
Role: PRINCIPAL_INVESTIGATOR
Shandong Provincial Hospital
Nan Jiang, M.D
Role: PRINCIPAL_INVESTIGATOR
Tianjin Chest Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wuhan Asia Heart Hospital
Wuhan, Hubei, China
Shandong Provincial Hospital
Jinan, Shandong, China
Tianjin Chest Hospital
Tianjin, Tianjin Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Perimount CN001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.